PR inside: Shareholder Alert: Robbins LLP Informs Investors of the RxSight,Inc. ...
(PR-inside.com) SAN DIEGO, CA / ACCESS Newswire / July 22, 2025 /Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (NASDAQ:RXST) securities between November 7, 2024 and July 8, 2025. RxSight is a commercial-stage medical technology company, engaged in the research and development, manufacture, and sale of light adjustable intraocular lenses ("LAL") used in cataract surgery in the United States. The Company's primary product is the RxSight system, which includes the LAL and a specially designed machine for delivering light to the eye, the Light Delivery Device ("LDD").
For more ..
https://reports.pr-inside.com/sharehold ... 121822.htm
Copyright PR-Inside.com 2025